Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. L'Oréal
  6. News
  7. Summary
    OR   FR0000120321

L'ORÉAL

(OR)
  Report
Real-time Euronext Paris  -  11:35:15 2023-02-07 am EST
376.85 EUR   -1.34%
07:49aLOREAL : JP Morgan remains Neutral
MD
02/07France's L'Oréal Says US Hair Relaxer Lawsuits Have No Merit
MT
02/06Nearly 60 hair relaxer lawsuits against L'Oreal, others consolidated in Illinois federal court
RE
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

L'Oreal : L'Oréal signs an agreement to acquire Skinbetter Science, a physician-dispensed American skincare brand

09/23/2022 | 02:20am EST

L'Oréal signed an agreement to acquire Skinbetter Science, a physician-dispensed American skincare brand backed by cutting-edge, dermatological science, combining patented efficacious ingredients with luxurious sensorial textures.

Skinbetter Science was co-founded in 2016 by pharmaceutical industry professionals, Jonah Shacknai, Justin Smith and Seth Rodner, and has since become one of the fastest growing medical-dispensed skincare brands in the United States. Skinbetter Science is known for formulating innovative products with active ingredients for anti-aging, moisturizing, cleansing, exfoliating, skin peeling and sun protection. The brand is strongly supported by deep knowledge of skin and chemistry with clinical trials led by board-certified dermatologists.

Skinbetter Science's products are mainly available through a network of leading dermatology, plastic surgery and medical aesthetics practices throughout the United States, powered by a national medical sales team.

Skinbetter Science recorded nearly USD 95 million of sales in the trailing-twelve-months that ended August 31, 2022. Headquartered in Arizona, the brand's leadership team will continue to run the business following the acquisition and will be integrated under the leadership of Christina Fair, President of the Active Cosmetics Division within L'Oréal USA.

Commenting on the acquisition, Myriam Cohen-Welgryn, Worldwide President of L'Oréal's Active Cosmetics Division, said, "Skinbetter Science is a perfect complement to the Active Cosmetics Division's brand portfolio. It will contribute greatly to the L'Oréal Active Cosmetics Division's long-standing mission to pioneer health and beauty with advanced science-based skincare innovations. I am confident this high-growth US brand has great international potential."

David Greenberg, Chief Executive Officer, L'Oréal USA and President, North America Zone, added, "We are thrilled to welcome the Skinbetter Science team to L'Oréal. I am confident the brand will strengthen our North America dermatological beauty business, an area that we believe has dynamic growth potential. Together with Christina Fair and our Active Cosmetics Division, we see an opportunity to draw on the strength of the fantastic team behind the brand and reinforce the relationships of trust that they have built with their healthcare professional partners to take this part of our business to the next level."

Jonah Shacknai, Founder & Executive Chairman of Skinbetter Science, said, "The entire Skinbetter Science team is excited to be joining the L'Oréal family. L'Oréal is the leading beauty company in the world, and its extraordinary leadership, resources and international reach will allow us to maximize opportunities for medical aesthetics practices, patients and our Skinbetter colleagues. We are very proud of all we have accomplished as an independent brand and look forward to collaboration with such an innovative and socially responsible global organization. We genuinely believe there to be superb mission and values alignment between our companies."

The closing is expected to occur in early Q4 2022, subject to the standard regulatory approvals and other customary conditions.

About L'Oréal
For over 110 years, L'Oréal, the world's leading beauty player, has devoted itself to one thing only: fulfilling the beauty aspirations of consumers around the world. Our purpose, to create the beauty that moves the world, defines our approach to beauty as inclusive, ethical, generous and committed to social and environmental sustainability. With our broad portfolio of 35 international brands and ambitious sustainability commitments in our L'Oréal for the Future programme, we offer each and every person around the world the best in terms of quality, efficacy, safety, sincerity and responsibility, while celebrating beauty in its infinite plurality.
With 85,400 committed employees, a balanced geographical footprint and sales across all distribution networks (e-commerce, mass market, department stores, pharmacies, hair salons, branded and travel retail), in 2021 the Group generated sales amounting to 32.28 billion euros. With 20 research centers across 11 countries around the world and a dedicated Research and Innovation team of over 4,000 scientists and 3,000 tech professionals, L'Oréal is focused on inventing the future of beauty and becoming a Beauty Tech powerhouse.
More information on https://www.loreal.com/en/mediaroom

"This press release does not constitute an offer of sale or solicitation of an offer to purchase L'Oréal shares. If you wish to obtain more comprehensive information about L'Oréal, please refer to the public documents registered in France with the Autorité des Marchés Financiers, also available in English on our website www.loreal-finance.com.
This press release may contain forecast information. While the Company believes that these statements are based on reasonable assumptions as of the date of publication of this press release, they are by nature subject to risks and uncertainties which may lead to a discrepancy between the actual figures and those indicated or suggested in these statements."

Contacts at L'Oréal

Individual shareholders and market authorities
Christian MUNICH
+33 (0)1 47 56 72 06
[email protected]

Financial analysts and Institutional investors
Françoise LAUVIN
+33 (0)1 47 56 86 82
[email protected]

Media
Noëlle CAMILLERI
+33 (0)6 79 92 99 39
[email protected]

Christine BURKE
+33 (0)6 75 54 38 15
[email protected]

Switchboard: +33 1 47 56 70 00

For further information, please contact your bank, stockbroker of financial institution (I.S.I.N. code: FR000012031), and consult your usual newspapers or magazines or the Internet site for shareholders and investors, www.loreal-finance.com, the L'Oréal Finance app or call the toll-free number from France: 0 800 66 66 66.

Disclaimer

L'Oréal SA published this content on 23 September 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 September 2022 06:19:02 UTC.


© Publicnow 2022
All news about L'ORÉAL
07:49aLOREAL : JP Morgan remains Neutral
MD
02/07France's L'Oréal Says US Hair Relaxer Lawsuits Have No Merit
MT
02/06Nearly 60 hair relaxer lawsuits against L'Oreal, others consolidated in Illinois federa..
RE
02/06U.S. employment weighs on markets
MS
02/03LOREAL : JP Morgan sticks Neutral
MD
02/02LOREAL : Credit Suisse reaffirms its Neutral rating
MD
02/02LOREAL : Goldman Sachs maintains a Buy rating
MD
02/01LOREAL : Deutsche Bank gives a Buy rating
MD
01/31LVMH, L'Oreal Mull Aesop Stake Bid, Bloomberg Reports
DJ
01/31LVMH, L’Oréal Reportedly Among Suitors for Stake in Aesop
CI
More news
Analyst Recommendations on L'ORÉAL
More recommendations
Financials
Sales 2022 38 140 M 40 792 M 40 792 M
Net income 2022 5 777 M 6 179 M 6 179 M
Net Debt 2022 1 155 M 1 236 M 1 236 M
P/E ratio 2022 35,3x
Yield 2022 1,49%
Capitalization 202 B 216 B 216 B
EV / Sales 2022 5,32x
EV / Sales 2023 4,97x
Nbr of Employees 85 412
Free-Float 37,5%
Chart L'ORÉAL
Duration : Period :
L'Oréal Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends L'ORÉAL
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 25
Last Close Price 381,95 €
Average target price 370,50 €
Spread / Average Target -3,00%
EPS Revisions
Managers and Directors
Nicolas Hieronimus Chief Executive Officer & Director
Christophe Babule Chief Financial Officer
Jean-Paul Agon Deputy Chief Executive Officer
Barbara Lavernos Deputy CEO-Research, Innovation & Technology
Antoine Vanlaeys Operations Director-Asia Pacific Zone
Sector and Competitors
1st jan.Capi. (M$)
L'ORÉAL14.49%219 470
SHISEIDO COMPANY, LIMITED0.25%19 532
KAO CORPORATION-2.42%17 963
COTY INC.19.39%8 637
YUNNAN BOTANEE BIO-TECHNOLOGY GROUP CO.LTD-8.34%8 323
AMOREPACIFIC CORPORATION8.44%7 283